Workflow
MEDLIVE(02192)
icon
Search documents
11月27日深港通医疗(983035)指数涨0.15%,成份股医脉通(02192)领涨
Sou Hu Cai Jing· 2025-11-27 11:10
证券之星消息,11月27日,深港通医疗(983035)指数报收于4494.42点,涨0.15%,成交75.2亿元,换 手率0.75%。当日该指数成份股中,上涨的有32家,医脉通以3.65%的涨幅领涨,下跌的有24家,健康之 路以3.41%的跌幅领跌。 资金流向方面,深港通医疗(983035)指数成份股当日主力资金净流出合计5882.68万元,游资资金净流 出合计1924.8万元,散户资金净流入合计7807.48万元。成份股资金流向详情见下表: | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300896 | 爱美客 | 4699.18万 | 11.04% | -1692.30万 | -3.98% | -3006.88万 | -7.07% | | 300760 迈瑞医疗 | | 3307.61万 | 2.35% | -1596.63万 | -1.14% | -1710.98万 | -1.22% | | 300206 理 ...
11月27日深港通医疗(港币)(983036)指数涨0.14%,成份股医脉通(02192)领涨
Sou Hu Cai Jing· 2025-11-27 11:10
证券之星消息,11月27日,深港通医疗(港币)(983036)指数报收于4391.58点,涨0.14%,成交82.59亿 元,换手率0.75%。当日该指数成份股中,上涨的有32家,医脉通以3.65%的涨幅领涨,下跌的有24家, 健康之路以3.41%的跌幅领跌。 深港通医疗(港币)(983036)指数十大成份股详情如下: | 深港通医疗(港币)指数 十大成份股 | | --- | | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 196.30 | 1.50% | 2380.02 | 医药生物 | | sz300015 | 爰尔眼科 | 11.62% | 11.40 | -0.26% | 1063.10 | 医药生物 | | sz300003 | 乐晋医疗 | 4.85% | 15.87 | 0.13% | 292.55 | 医药生物 | | sz300896 | 爱美客 | 4.80% | 146.26 | 0.83% ...
医脉通投资者关系负责人胡慧楠:深耕医生服务平台,以AI技术赋能医疗专业生态|聚焦2025华夏大健康
Hua Xia Shi Bao· 2025-11-22 14:39
Core Insights - The core viewpoint emphasizes that data is fundamental, AI technology is the driving force for development, and commercialization is the ultimate goal in AI healthcare [2][5]. Group 1: AI Technology in Healthcare - The company, as a leading online professional doctor platform, has over 7 million registered users, with more than 4 million being licensed physicians, covering 88% of the physician community in China [3]. - The company has developed a medical vertical large model through independent research and has received approval from the National Internet Information Office, enabling intelligent clinical decision support for doctors [3]. - AI products have demonstrated significant value, providing traceable answers to clinical questions, ensuring information accuracy and reliability for physicians [3]. Group 2: Business Model and Commercialization - The company focuses on the pharmaceutical and medical device sectors, particularly in prescription drug markets, to conduct targeted academic education for doctors [5]. - The core logic of the business model is to leverage strong physician resources to enhance the efficiency of academic marketing and provide professional academic support to doctors [5]. - The company has achieved over 30% annual revenue growth and maintains a strong net profit margin, supporting ongoing investments in AI technology [5]. Group 3: Future Development and Industry Impact - The company has established a virtuous cycle between AI technology and commercial applications, contributing to the digital transformation of the healthcare industry [5].
智通港股通资金流向统计(T+2)|11月10日
智通财经网· 2025-11-09 23:32
Core Insights - Southbound funds saw significant inflows into Southern Hang Seng Technology, Alibaba-W, and Xiaomi Group-W, with net inflows of 1.286 billion, 0.885 billion, and 0.650 billion respectively [1][2] - Conversely, Huahong Semiconductor, SMIC, and Bilibili-W experienced the largest net outflows, with amounts of -0.642 billion, -0.505 billion, and -0.188 billion respectively [1][2] Net Inflow Summary - The top three stocks by net inflow were: - Southern Hang Seng Technology (03033) with a net inflow of 1.286 billion and a closing price of 5.670 (-0.61%) [2] - Alibaba-W (09988) with a net inflow of 0.885 billion and a closing price of 158.500 (-0.31%) [2] - Xiaomi Group-W (01810) with a net inflow of 0.650 billion and a closing price of 43.320 (-0.23%) [2] Net Outflow Summary - The top three stocks by net outflow were: - Huahong Semiconductor (01347) with a net outflow of -0.642 billion and a closing price of 73.450 (-3.10%) [2] - SMIC (00981) with a net outflow of -0.505 billion and a closing price of 71.700 (-0.21%) [2] - Bilibili-W (09626) with a net outflow of -0.188 billion and a closing price of 220.200 (-4.09%) [2] Net Inflow Ratio Summary - The top three stocks by net inflow ratio were: - Qingdao Bank (03866) with a net inflow ratio of 83.58% and a closing price of 4.240 (-1.17%) [1][2] - China Communication Construction (03969) with a net inflow ratio of 56.27% and a closing price of 3.490 (+1.16%) [2] - Datang New Energy (01798) with a net inflow ratio of 55.14% and a closing price of 2.470 (+0.82%) [2] Net Outflow Ratio Summary - The top three stocks by net outflow ratio were: - Yimaitong (02192) with a net outflow ratio of -51.15% and a closing price of 10.210 (+0.39%) [3] - China Oriental Education (00667) with a net outflow ratio of -48.49% and a closing price of 6.310 (-2.77%) [3] - Gushengtang (02273) with a net outflow ratio of -46.32% and a closing price of 28.180 (-1.33%) [3]
医脉通 2192.HK
Core Insights - The article discusses the recent financial performance of a leading technology company, highlighting a significant increase in revenue and net profit for the last quarter [1] - It emphasizes the company's strategic investments in research and development, which are expected to drive future growth [1] Financial Performance - The company reported a revenue of $5 billion for the last quarter, representing a 20% increase year-over-year [1] - Net profit reached $1 billion, marking a 25% increase compared to the same period last year [1] Strategic Initiatives - The company has increased its R&D spending by 15%, focusing on innovative technologies and product development [1] - Plans to expand into new markets were also outlined, with an emphasis on enhancing global presence [1] Market Position - The company maintains a strong competitive position within the technology sector, with a market share of approximately 30% [1] - Recent partnerships with other tech firms are expected to bolster its market position further [1]
医脉通荣膺“社会责任金牛奖”
Zhong Zheng Wang· 2025-11-08 08:19
Core Viewpoint - The article highlights the recognition of the company, Yimaitong, for its social responsibility efforts in the healthcare sector, as it received the "Social Responsibility Golden Bull Award" at the 2025 Xiamen Industrial Development Conference [1] Group 1: Company Achievements - Yimaitong has been acknowledged for its commitment to corporate social responsibility, contributing to the advancement of the healthcare industry and giving back to society [1] - Since its establishment in 1996, the company has focused on user needs and integrated social responsibility into its business strategy, amassing over 7 million registered users, including more than 4 million licensed physicians, which represents 88% of China's total licensed physicians [1] Group 2: Innovation and Development - The company emphasizes technological innovation to address unmet clinical needs, forming a multidisciplinary R&D team and investing heavily in research resources [2] - Yimaitong is actively enhancing grassroots medical capabilities through collaborations with national health authorities, covering over 600 industry experts and more than 50,000 grassroots doctors in training programs [2] Group 3: Environmental and Social Responsibility - Yimaitong promotes low-carbon development in healthcare services through digital transformation, achieving a reduction of approximately 6,300 tons of CO2 equivalent emissions in 2024 [3] - The company engages in public welfare by providing free medical 3D teaching resources to support youth biological education and has been recognized for its contributions to the field of myasthenia gravis [3] - The company plans to continue leveraging technology to enhance medical digital innovation and fulfill its social responsibility commitments [3]
智通港股通资金流向统计(T+2)|11月7日
智通财经网· 2025-11-06 23:34
Key Points - The top three companies with net inflows of southbound funds are China National Offshore Oil Corporation (CNOOC), Xiaomi Group, and Southern Hang Seng Technology, with net inflows of 1.045 billion, 0.998 billion, and 0.766 billion respectively [1] - The top three companies with net outflows of southbound funds are Alibaba Group, Sunny Optical Technology, and Luoyang Molybdenum, with net outflows of -0.873 billion, -0.339 billion, and -0.254 billion respectively [1] - In terms of net inflow ratio, Qingdao Bank, Dasheng Holdings, and Shougang Resources lead the market with ratios of 86.77%, 70.86%, and 63.91% respectively [1] - The companies with the highest net outflow ratios are Pacific Basin Shipping, Yimaitong, and Sichuan Chengyu Expressway, with ratios of -54.77%, -46.94%, and -37.64% respectively [1] Net Inflow Rankings - The top ten companies by net inflow include CNOOC (1.045 billion), Xiaomi Group (0.998 billion), and Southern Hang Seng Technology (0.766 billion) [2] - Other notable companies in the net inflow list are China Mobile (0.752 billion), Industrial and Commercial Bank of China (0.531 billion), and China Petroleum (0.431 billion) [2] Net Outflow Rankings - The top ten companies by net outflow include Alibaba Group (-0.873 billion), Sunny Optical Technology (-0.339 billion), and Luoyang Molybdenum (-0.254 billion) [2] - Other significant companies with net outflows are SMIC (-0.240 billion), Jiangxi Copper (-0.220 billion), and Bilibili (-0.200 billion) [2] Net Inflow Ratio Rankings - The top three companies by net inflow ratio are Qingdao Bank (86.77%), Dasheng Holdings (70.86%), and Shougang Resources (63.91%) [2][3] - Other companies with high net inflow ratios include Wanwuyun (61.22%) and Prudential (60.12%) [3] Net Outflow Ratio Rankings - The top three companies by net outflow ratio are Pacific Basin Shipping (-54.77%), Yimaitong (-46.94%), and Sichuan Chengyu Expressway (-37.64%) [3] - Other companies with significant net outflow ratios include Yancoal Australia (-34.65%) and Lens Technology (-33.16%) [3]
医脉通(02192) - 截至二零二五年十月三十一日止月份之股份发行人的证券变动月报表
2025-11-04 09:23
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 醫脈通科技有限公司 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02192 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 50,000,000,000 | USD | | 0.00001 | USD | | 500,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 50,000,000,000 | USD | | 0.00001 | USD | | 500,000 | 本月底 ...
智通港股通资金流向统计(T+2)|11月3日
智通财经网· 2025-11-02 23:32
Core Insights - The article highlights the net inflow and outflow of funds for various companies in the Hong Kong stock market, indicating significant movements in investor sentiment and market dynamics [1][2][3] Net Inflow Summary - The top three companies with the highest net inflow of funds are Huahong Semiconductor (华虹半导体) with 388 million, Pop Mart (泡泡玛特) with 320 million, and Qingdao Beer (青岛啤酒股份) with 305 million [1][2] - The net inflow percentages for these companies are 8.15%, 7.92%, and 58.54% respectively, indicating strong investor interest, particularly in Qingdao Beer [2][3] Net Outflow Summary - The companies with the highest net outflow of funds include Alibaba-W (阿里巴巴-W) with -523 million, Southern Hang Seng Technology (南方恒生科技) with -429 million, and Tencent Holdings (腾讯控股) with -355 million [1][2] - The net outflow percentages for these companies are -3.89%, -4.86%, and -3.36% respectively, reflecting a negative sentiment among investors towards these stocks [2][3] Net Inflow Ratio Summary - The companies with the highest net inflow ratios are Shenzhen Expressway (深圳高速公路股份) at 68.48%, Anhui Wanshan Expressway (安徽皖通高速公路) at 64.22%, and Legend Holdings (联想控股) at 59.98% [1][3] - These ratios suggest a strong demand for shares in these companies relative to their trading volume [3] Net Outflow Ratio Summary - The companies with the highest net outflow ratios are Huadian International Power (华电国际电力股份) at -62.31%, CIMC Enric (中集安瑞科) at -54.98%, and Connoisseur-B (康诺亚-B) at -52.78% [1][3] - These figures indicate significant selling pressure and a lack of confidence among investors in these stocks [3]
医脉通因购股权获行使而发行53.45万股
Zhi Tong Cai Jing· 2025-10-15 23:47
Core Points - The company, 医脉通 (02192), announced the issuance of 534,500 ordinary shares to a director exercising stock options under the pre-IPO stock option plan adopted on March 29, 2021 [1] Summary by Category Company Actions - The issuance of shares is scheduled for October 15, 2025, as part of the stock option plan [1]